Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cridanimod (1 trial)
Carcinoma (Phase 2)
Endometrial Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (1 total)